NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

TSX · Pharmaceutical Retailers · CAD

TelyRx Holdings Inc. (TELY.TO) Stock Analysis

TelyRx Holdings Inc. (TELY.TO) is a Pharmaceutical Retailers stock listed on TSX and quoted in Canadian Dollar.

Last Updated: October 21, 2026

TELY.TO

CA$2.50

CA$0.00 (0.00%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare TELY.TO with… →

TELY.TO Key Statistics

As of Oct 21, 2026
Trading
Open
CA$2.46
Previous Close
CA$2.50
Day's Range
2.45–2.50
52-Week Range
2.00–4.25
Volume
3.61K
Valuation
Market Cap
CA$66.48M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
9.96
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.97
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.69
Financials (FY)
Revenue (FY)
CA$42.92M+350.27%
Net Income (FY)
−CA$5.43M
Profit marginThe share of revenue left as profit after all costs and taxes.
−19.36%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
26.37M
Dividend and dates
Avg Volume
21.66K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

TelyRx Holdings Inc. (TELY.TO) has a market capitalization of CA$66.48M.

In fiscal 2025, TELY.TO reported revenue of CA$42.92M.

TELY.TO Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025CA$42.92M−CA$5.43M−12.6%
2024CA$9.53M−CA$13.48M−141.4%
2023CA$27.00K−CA$4.39M−16,274.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025CA$42.92MCA$23.32M−CA$4.76M−CA$5.43M−12.6%
2024CA$9.53MCA$3.51M−CA$3.93M−CA$13.48M−141.4%
2023CA$27.00KCA$2.00K−CA$746.00K−CA$4.39M−16,274.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

TELY.TO Valuation vs Pharmaceutical Retailers Median

Median of 6 stocks
MetricTELY.TOPharmaceutical Retailers medianvs median
P/S ratio0.970.244.0x the median
Profit margin−19.36%−17.34%2.0 pts below

Medians across 6 Pharmaceutical Retailers stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

TelyRx Holdings Inc. (TELY.TO) carries a market capitalisation of CA$66.48M. The company sits in the Healthcare sector, in the Pharmaceutical Retailers industry.

The 52-week range on file runs from CA$2.00 to CA$4.25. TELY.TO last closed at CA$2.50 on October 21, 2026. The close was unchanged from the previous session. The latest close sits 25% above that 52-week low.

Financial Health

In fiscal 2025, TelyRx Holdings Inc. reported revenue of CA$42.92M. That is +350.27% against the prior fiscal year, when revenue was CA$9.53M. The same year closed with a net loss of CA$5.43M. The reported profit margin is −19.36%. That is 2 percentage points below the Pharmaceutical Retailers median of −17.34%. Earnings per share on a trailing basis come to −0.69.

Across the 3 fiscal years on file, revenue moves from CA$27.00K in 2023 to CA$42.92M in 2025. Of those 3 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 9.96. The price-to-sales ratio is 0.97. On price-to-sales that is 4 times the Pharmaceutical Retailers median of 0.24. The medians here are taken across 6 Pharmaceutical Retailers companies that report the metric.

The stored price history starts on April 7, 2026, and the total return since then is −28.57%.

Growth & Income

The record shows no dividend for TELY.TO.

So far in 2026 the total return is −28.57%.

Peer Comparison

TelyRx Holdings Inc. (TELY.TO) operates in the Pharmaceutical Retailers industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
TelyRx Holdings Inc. TELY.TO CA$66.48M —
High Tide Inc. HITI $240.69M —
Pomdoctor Limited POM $27.90M —
PetMed Express, Inc. PETS $25.80M —

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Pharmaceutical Retailers Stocks

HITI

High Tide Inc.

$240.69M

 POM

Pomdoctor Limited

$27.90M

 PETS

PetMed Express, Inc.

$25.80M

 SCNX

Scienture Holdings, Inc.

$4.77M

 RDGT

Ridgetech, Inc.

$2.98M
View all Pharmaceutical Retailers stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About TelyRx Holdings Inc.

TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida.

Visit website →